Opus Genetics (IRD) Amortization of Deferred Charges (2010 - 2017)
Opus Genetics' (IRD) quarterly Amortization of Deferred Charges came in at $219577.0 in Q4 2017, down 34.07% on a QoQ basis from $333050.0 in Q2 2017.
Opus Genetics (IRD) Amortization of Deferred Charges (2010 - 2017) Analysis & Trends
Opus Genetics (IRD) has 6 years of Amortization of Deferred Charges data on file, last reported at $219577.0 in Q4 2017.
- On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $219577.0 in Q4 2017; TTM through Dec 2017 was $552627.0, a 76.51% increase from a year earlier, with the FY2017 full-year figure at $552627.0, up 76.51% from the prior year.
- Amortization of Deferred Charges for Q4 2017 stood at $219577.0, down from $333050.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for IRD reached as high as $333050.0 in Q2 2017 and fell as low as $91653.0 in Q4 2013.
- Historically, Amortization of Deferred Charges has averaged $182300.1 across 4 years, with a median of $169887.0 in 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 219,577.00 |
| Dec 31, 2017 | 219,577.00 |
| Jun 30, 2017 | 333,050.00 |
| Jun 30, 2017 | 333,050.00 |
| Sep 30, 2016 | 143,203.00 |
| Sep 30, 2016 | 143,203.00 |
| Mar 31, 2016 | 169,887.00 |
| Mar 31, 2016 | 169,887.00 |
| Mar 31, 2014 | 206,172.00 |
| Mar 31, 2014 | 206,172.00 |
| Dec 31, 2013 | 91,653.00 |
| Dec 31, 2013 | 91,653.00 |
| Sep 30, 2013 | 112,559.00 |
| Sep 30, 2013 | 112,559.00 |
| Mar 31, 2011 | 97,667.00 |
| Mar 31, 2011 | 97,667.00 |
| Jun 30, 2010 | 180,080.00 |
| Jun 30, 2010 | 180,080.00 |